The Launch Excellence Lead (LX) will lead early stages of asset strategic planning across all BU’s and provide a single point of contact for pipeline strategic planning and optimisation for the Malaysia business. The LX will work with cross-functional teams in advance of progression to Phase 3 clinical trials and lead the relevant XFTs to assess, prioritise and plan for each pipeline asset to maximise launch success to generate optimal patient access and commercial return on investment. The LX will play a critical role in ensuring local gaps and issues are identified early, develop a thorough understanding of customer needs, and advocate and influence global asset teams and local stakeholders to implement initiatives to maximise launch potential. The LX will be firmly focused in early stage pipeline management and provide guidance on key launch milestones – including handover point to the relevant brand manager in advance of market launch.
This individual will proactively lead the most important milestones for all successful launches and requires solid experience in launch excellence, project management and in developing extraordinary partnerships with internal and external stakeholders; will ensure coordination and tracking of plan; identification of cross-functional interdependencies; escalation of critical issues and pressure testing Market Model (GTM) assumptions.
This role is an unique opportunity to demonstrate strong business acumen and cross-functional leadership, driven by a strong understanding of health systems and interdependencies. Also, because of the unprecedented situation of planning for a launch for an asset under emergency authorization, the role will require high flexibility, ability to drive change and deal with uncertainty, proven experience in delivering creative approaches to solve issues, and track record of working Glocally with challenging deadlines.
Provide strategic leadership for pipeline planning and optimisation
Provide a single point of contact for pipeline strategic planning and optimisation for the Malaysia business.
Lead the relevant XFTs to assess, prioritise and plan for each pipeline asset to ensure optimal patient access and commercial return on investment
Liaise with global asset teams (clinical, medical affairs, regulatory, pricing, commercial, launch navigation) to ensure local input at critical timepoints in asset development.
Develop local needs/gap analysis and implement/advocate for local initiatives to improve launch potential.
Incremental investment strategies for continued launch success (i.e. expanded access)
Provide Strategic Direction and Seamless Franchise Coordination
Analyse MY landscape – clinical data, competitive landscape, customer needs, access and payer environment, global pricing, etc. to identify key strategic issues and decisions that impact MY launch planning
Ensure coordinated decision making, registration sequencing and resource allocation to maximise value for MY
In partnership with brand manager, refine brand position, pricing, go-to-market approach, and other core elements of launch based on local market and competitive landscape
Key point of contact for Local and Global Business Development opportunities. Integrates the same XFT approach and governance for local market assessments.
Drive Launch Excellence
Provide key commercial insights into all XFT workstreams (value proposition and critical success factor development, launch strategy, timings, etc) ensuring customer needs are central in all decisions/initiatives.
Form and lead the brand specific XFT (regulatory, access, medical, supply, pricing) until handover to the relevant brand manager.
Ensure launch platform is fully developed and optimised for success
Active member of Global Launch Navigation group and across best practice and expert resources (digital, customer experience)
Drive development of the local Tactical plan, Market Research and Launch Readiness workshops for NPL.
Lead and plan for pre-launch activities, including disease awareness campaigns & market research activities.
Support the implementation and management of DLPP (Digital Launch Planning Platform)
Developing the MY Paxlovid, Dermatology pipelines and other new product launch plans (forecasting, brand plans, tactical plans, insights etc)
Assess and lead business case development for incremental funding requests
Provide leadership to local brand team
Handover to relevant BU lead and brand manager once a meaningful local market investment is required
Work with patient ambassador and local brand team on HCP engagement, consumer engagement, education
Embed a ‘customer curious’ mindset in the local brand team to ensure patients and clinician needs are at the centre of all launch initiatives.
Base degree Science, Business or equivalent. Advanced degree a plus.
5-10 Years marketing experience, leading and driving commercial strategy
Strong understanding of local access, regulatory and medical environments
Experience in product launches
Strong strategic and analytical capabilities
Comfort with ambiguity and complex “white space” environments
Ability to influence and collaborate without authority in a matrix environment
An unrelenting curiosity to understand and champion customer needs.
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
Marketing and Market Research#LI-PFE
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place. Every day, our colleagues work in developed and emerging markets to ...